Used in pharmaceutical research as an intermediate in the synthesis of biologically active compounds, particularly in the development of central nervous system agents. The 8-bromo substituent at the quinoline ring enables versatile chemical transformations, such as cross-coupling or nucleophilic substitution reactions, to generate diverse derivatives for structure-activity relationship (SAR) studies. Shows potential in the study of neurological disorders due to its structural similarity to dopamine receptor ligands. Also employed in the preparation of novel quinoline derivatives for screening in anti-inflammatory and anticancer assays. Commonly utilized in medicinal chemistry involving substituted dihydroquinolinones.